Home Compare AFX.DE vs SOON.SW
Stock Comparison · Single-driver result

Carl Zeiss Meditec vs Sonova Holding: Which Stock Looks Stronger in 2026?

The structural profiles are close, with Sonova carrying a narrow edge on profitability. Carl Zeiss Meditec still has the edge on valuation, which keeps the comparison from looking entirely one-sided. Both sides have seen trend damage — neither carries a clear market edge right now. With both trends damaged, the structural comparison carries most of the weight here.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The lead runs through profitability, while valuation still acts as a real counterweight on the other side.

Trajectory Similarity
0.71
Similar
Peer-set rank: #5
within Carl Zeiss Meditec AG's functional peer set

This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.

The pair sits on a clearly comparable long-term path, though it is not a near-twin match.

The match is driven mainly by capital structure and revenue stability.

Similarity drivers
capital structurerevenue stability
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
AFX.DE
Carl Zeiss Meditec AG
47
Peer-Score
Signal qualityHigh
vs
SOON.SW
Sonova Holding AG
49
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The clearest separation appears in profitability.

Dimension spread: AFX.DE vs SOON.SW Profitability 35 66 Stability 24 28 Valuation 86 62 Growth 28 25 AFX.DE SOON.SW
Gap Ranking
#1 Profitability +31
#2 Valuation +24
#3 Stability +4
#4 Growth +3
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for AFX.DE and SOON.SW Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer AFX.DESOON.SW Relative valuation Structural strength

Sonova Holding AG occupies the cheaper side of the setup map, although Carl Zeiss Meditec AG still holds the stronger structural profile.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Profitability
On profitability, Sonova Holding AG ranks near the top of the group; Carl Zeiss Meditec AG sits in the weaker half.
Valuation
On valuation, the same pattern holds: both are strong, but Carl Zeiss Meditec AG still leads clearly.
Profitability — Dominant Gap
AFX.DE
35
SOON.SW
66
Gap+31in favour of SOON.SW

The profitability lead is mainly driven by a 14.4-point operating margin advantage.

What keeps the gap from being one-sided

Absolute pricing still looks more supportive for Carl Zeiss Meditec, with a forward P/E that is 4.2 turns lower there.

What this means for the comparison

The main read on profitability is clearer than the broader score gap.

Explore full peer positioning in AssetNext

Break down the AFX.DE vs SOON.SW comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how AFX.DE and SOON.SW each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.